| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/18/2009 | EP2024390A1 Insulin derivative |
| 02/18/2009 | EP2024389A2 Imaging agent |
| 02/18/2009 | EP2024386A2 Use of proteins and peptides of the tgf-beta superfamily for purification and therapeutic methods |
| 02/18/2009 | EP2023962A2 Human oct-2 variant peptide chains, nucleic acids, and methods |
| 02/18/2009 | EP2023941A2 Protein crosslinkers, crosslinking methods and applications thereof |
| 02/18/2009 | EP1919945A4 Mutant of granulocyte-colony stimulating factor(g-csf) and chemically conjugated polypeptide thereof |
| 02/18/2009 | EP1904522B1 Method for the purification of g-csf |
| 02/18/2009 | EP1799234A4 Enhancing recombinant hemoglobin production by co-expression with alpha hemoglobin stabilizing protein |
| 02/18/2009 | EP1679372B1 Novel plexin polypeptide, dna encoding the same and use thereof |
| 02/18/2009 | EP1636260B1 Improved secretion of neublastin |
| 02/18/2009 | EP1575967B1 Process for the extraction and isolation of insulin from recombinant sources |
| 02/18/2009 | EP1572094B1 Sodium channel alpha subunit variants |
| 02/18/2009 | EP1569958B1 Methods and materials for treating inflammatory conditions using a polypeptide comprising a self-c5 amino acid segment and a non-self amino acid segment |
| 02/18/2009 | EP1555325B1 Novel fructosyl peptide oxidase and utilization thereof |
| 02/18/2009 | EP1458757B1 Process for the purification and/or isolation of biologically active granulocyte colony stimulating factor |
| 02/18/2009 | EP1196447B1 Method for stabilising proteins in complex mixtures during their storage in aqueous solvents |
| 02/18/2009 | EP1140157B1 Streptococcus pneumoniae proteins and immunogenic fragments for vaccines |
| 02/18/2009 | EP1135467B1 Psca: prostate stem cell antigen and uses thereof |
| 02/18/2009 | EP1104405B1 Near infrared chemiluminescent acridinium compounds and uses thereof |
| 02/18/2009 | EP1071955B2 Improved immunodiagnostic assays using reducing agents |
| 02/18/2009 | EP1071797B1 A method for isolating a polynucleotide of interest from the genome of a mycobacterium using a bac-based dna library. application to the detection of mycobacteria |
| 02/18/2009 | EP0965041B1 A method of identifying modulators of cell surface membrane receptors useful in the treatment of disease |
| 02/18/2009 | EP0941337B1 Synthesis and purification of hepatitis c virus-like particles |
| 02/18/2009 | EP0922761B1 Monoclonal antibody specific to anti-human fibrin monomer, process for producing the same, hybridomas, and immunoassay method |
| 02/18/2009 | EP0716709B1 Enhanced expression in plants using non-translated leader sequences |
| 02/18/2009 | EP0673415B1 Recombinant viral vector system |
| 02/18/2009 | CN101370937A Nucleotide sequence and corresponding polypeptide for endowing plant with adjusted growth velocity and biomass |
| 02/18/2009 | CN101370825A Novel FSH glycosylation variant D3N |
| 02/18/2009 | CN101370824A A novel binding site for retigabine on KCNQ5 |
| 02/18/2009 | CN101370823A Luminescent stem cells and uses thereof |
| 02/18/2009 | CN101370822A Keratin-binding effector molecules containing reactive dyes |
| 02/18/2009 | CN101370821A Novel peptide and uses thereof |
| 02/18/2009 | CN101370516A Soluble fragments of the SARS-CoV spike glycoprotein |
| 02/18/2009 | CN101370514A Neisseria meningitidis vaccines and their use |
| 02/18/2009 | CN101370511A Activin-ActRlla antagonists and uses for promoting bone growth |
| 02/18/2009 | CN101368183A Preparation of tomato EIL1 recombinant protein and uses thereof |
| 02/18/2009 | CN101368182A Gene ZmAl1 isogenous with arabidopsis thaliana ARGOS for governing size of organ in corn |
| 02/18/2009 | CN101367877A Monkey monoclonal antibodies specific to human B7.1 and/or B7.2 primatized forms, pharmaceutical compositions |
| 02/18/2009 | CN101367873A Modified glucagon sample peptide-1analogue and modifying matter, and uses thereof |
| 02/18/2009 | CN101367872A Protein-polymer conjugates |
| 02/18/2009 | CN101367871A Snake venom protein component of ahylysantinfarctase at southern Anhui Province, extraction method and uses thereof |
| 02/18/2009 | CN101367870A Bovine rotavirus recombinant VP6 protein antigen and method of preparing the same |
| 02/18/2009 | CN101367869A Polypeptide for preventing, diagnosing and treating hepatitis E virus, and vaccine as diagnosis agent of the same |
| 02/18/2009 | CN101367865A Production process for high purity porcine blood albumin and uses thereof |
| 02/18/2009 | CN100462437C A fungal immuromodulatory protein produced by microorganisme and uses there of |
| 02/18/2009 | CN100462435C Gene imparting redifferentiation ability of plant, and utilization of the same |
| 02/18/2009 | CN100462370C Process for purifying interferon beta |
| 02/18/2009 | CN100462369C Transcription factor of regulating and controlling vegetable fatty acid metabolism and its coding gene and application |
| 02/18/2009 | CN100462368C Halophilic bacteria and its immune protein and genes encoding same and use thereof |
| 02/17/2009 | US7491814 A cDNA-primer MgRT3a oligonucleotide, a second primer that hybridizes to a calibrator mRNA that is porphobilinogen desaminase mRNA; quantitative analysis |
| 02/17/2009 | US7491809 Polynucleotides encoding human cytokine receptor |
| 02/17/2009 | US7491800 Cytokine zalpha11 ligand fusion proteins |
| 02/17/2009 | US7491799 Modified botulinum neurotoxins |
| 02/17/2009 | US7491798 Scytovirins and related conjugates, fusion proteins, nucleic acids, vectors, host cells, compositions, antibodies and methods of using scytovirins |
| 02/17/2009 | US7491797 PRO6308 polypeptide |
| 02/17/2009 | US7491796 Retro-inversion peptides that target GIT receptors and related methods |
| 02/17/2009 | US7491795 Neuropeptides and their use for pest control |
| 02/17/2009 | US7491731 Crystal structure of liganded cFMS kinase domain |
| 02/17/2009 | US7491707 Synthetic lipid-a-analogs and uses thereof |
| 02/17/2009 | US7491702 X1-Ser-Met-Arg-Glu-Arg-X2 in which X1 and X2 are up to 30 amino acid residues and the formula represents a reverse-order sequence corresponding to amino acid residues 332 to 328 of human APP and from zero to 30 successive amino acid residues |
| 02/17/2009 | US7491701 Peptides that bind to HSP90 proteins |
| 02/17/2009 | US7491699 Peptide nanostructures and methods of generating and using the same |
| 02/17/2009 | US7491698 Mixing and matching TC proteins for pest control |
| 02/17/2009 | US7491697 Muteins of fibroblast growth factor 21 |
| 02/17/2009 | US7491696 Proteolysis resistant active VEGF |
| 02/17/2009 | US7491694 Dental restorative materials |
| 02/17/2009 | US7491693 Administering High Density Lipoproteins |
| 02/17/2009 | US7491692 admixing a supplement selected from the therapeutically active agents for facilitating axon growth and a flowable carrier component capable of forming a matrix in vivo at a nerve lesion site and the active agent is releasable from the matrix |
| 02/17/2009 | US7491691 Bone and/or cartilage development-stimulating peptide incorporating proline or hydroxyproline; implants |
| 02/17/2009 | US7491543 Biological markers for longevity and diseases and uses thereof |
| 02/17/2009 | US7491533 Polynucleotides encoding an isolated β-islet cell two-pore domain potassium channel |
| 02/17/2009 | US7491532 Recombinant protein production in a human cell |
| 02/17/2009 | US7491530 Hybrid cell for producing immunoglobulins for diagnosis and treatment of cell proliferative, infectious autoimmune and tumor disorders |
| 02/17/2009 | US7491529 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/17/2009 | US7491528 Method for extracellular production of target proteins employing OmpF in E. coli |
| 02/17/2009 | US7491525 Specific proliferation in tumour cell which can express antioncogene with high efficiency and the use of it |
| 02/17/2009 | US7491523 Voltage-dependent calcium channel beta subunit functional core |
| 02/17/2009 | US7491521 Rhodococcus nitrile hydratase |
| 02/17/2009 | US7491515 Recombinant polypeptides for diagnosing infection with Trypanosoma cruzi |
| 02/17/2009 | US7491513 Composition and method for treating lupus nephritis |
| 02/17/2009 | US7491512 recombinant production of polypeptides having sequence similarity to interleukin-17 and interleukin-17 receptor protein; from E. coli, or yeast cell; vectors, host cells; produce immunostimulants, immunosuppressants, agonists, antagonists, biodrugs |
| 02/17/2009 | US7491511 isolated nucleic acid encoding a fungal antigen from Candida albicans; antiallergenic reaction to fungi in a vertebrate; and diagnosing a disease caused by fungi in a vertebrate; desensitization therapy for vaccines; insoluble cytoplasmic membrane proteins, free of cell wall |
| 02/17/2009 | US7491509 Viral expression vector for transfer and expression of heterologous gene in plants; bioreactors |
| 02/17/2009 | US7491508 termini grow efficiently in desired cell line; left terminus spans the 5' inverted terminal repeat, left terminus spans the E4 region and the 3' inverted terminal repeat; internal regions does not grow efficiently in the desired cell; adenovirus vectors use for gene therapy; culturing; vaccines |
| 02/17/2009 | US7491507 Using lactobacillus to ferment hypotensive agents comprised of milk protein amino acid sequences; treatment for hypertension |
| 02/17/2009 | US7491503 Identification of ligands by selective amplification of cells transfected with receptors |
| 02/17/2009 | US7491500 Mammalian cytokine; related reagents |
| 02/17/2009 | US7491490 For inhibition of viral entry into cells |
| 02/17/2009 | US7491405 Antigenic protein originating in Malassezia |
| 02/17/2009 | US7491402 Superantigens SMEZ-2, SPE-G, SPE-H and SPE-J and uses thereof |
| 02/17/2009 | US7491401 Lawsonia intracellularis vaccine |
| 02/17/2009 | US7491398 Proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |
| 02/17/2009 | US7491397 Receptor binding polypeptides |
| 02/17/2009 | US7491396 peptides; reduced allergenic activity as compared to Phl p 2 wild type; vaccine; biodrug |
| 02/17/2009 | US7491384 administering enothelial growth factors with delivery vehicle (powdered bone, tricalcium phosphate, hydroxyapatite, polymethacrylate, biodegradable polyester, aqueous polymeric gel, or fibrin sealant) |
| 02/17/2009 | CA2637346A1 Muscle lamin a/c interacting protein, gene encoding same, and uses therefor |
| 02/17/2009 | CA2473101C Immunoassays |
| 02/17/2009 | CA2406884C Novel collectins |
| 02/17/2009 | CA2340934C Novel collectin |
| 02/17/2009 | CA2318030C Acpl dna and polypeptides |